Protagenic Therapeutics, Inc.
Balance Sheet
| Line Item | FY2026 | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 |
|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||
| Cash & Equivalents | $1.5M | $14.5K | $1.6K | — | — | — | $671.1K | $798.6K |
| Accounts Receivable | — | — | — | — | — | — | — | — |
| Inventory | — | $1.0K | — | — | — | — | — | — |
| Total Current Assets | $1.5M | $89.1K | $1.9M | $4.2M | $8.0M | $11.1M | $879.2K | $842.0K |
| Property, Plant & Equipment | $14.6K | — | $73.0K | $123.3K | $1.8K | — | — | $296 |
| Goodwill | — | — | — | — | — | — | — | — |
| Intangible Assets (Excl. Goodwill) | $2.1M | — | — | — | — | — | — | — |
| Total Assets | $3.7M | $89.1K | $2.0M | $4.3M | $8.0M | $11.1M | $879.2K | $842.3K |
| Liabilities | ||||||||
| Accounts Payable | $949.5K | $961.1K | — | — | $669.7K | $499.5K | $571.5K | $865.0K |
| Total Current Liabilities | $1.0M | $5.0M | $942.8K | $655.3K | $1.1M | $799.5K | $655.2K | $1.2M |
| Long-Term Debt | — | — | — | — | — | — | — | — |
| Total Liabilities | $1.0M | $5.0M | $942.8K | $655.3K | $1.1M | $1.1M | $2.0M | $1.5M |
| Stockholders' Equity | ||||||||
| Retained Earnings | $-4.0M | $-5.4M | $-36.3M | $-30.8M | $-25.8M | $-22.2M | $-17.7M | $-15.2M |
| Total Stockholders' Equity | $2.6M | $-5.0M | $1.0M | $3.7M | $6.9M | $9.9M | $-1.1M | $-634.4K |